Mereo BioPharma (AgeTech UK) Biomed
Kinase inhibitors and other in pipeline for various, inclusing COPD. Mission is to provide new therapies to patients with chronically debilitating and life limiting rare diseases that have few, if any, other treatment options.
Headquarters:
United Kingdom
Funding Status:
N/A
Employee Number:
N/A
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
AgeTech Companies
Investor Type:
N/A
Founded Date:
N/A
Industry:
UK AgeTech 2020